Silk Road Medical Inc (SILK)
NASDAQ: SILK
· Real-Time Price · USD
27.49
-0.01 (-0.04%)
At close: Sep 16, 2024, 10:00 PM
Silk Road Medical Inc Income Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Revenue | 191.43M | 185.49M | 177.13M | 169.93M | 162.87M | 150.75M | 138.64M | 126.83M | 114.16M | 107.44M | 101.47M | 94.34M | 89.71M | 78.35M |
Cost of Revenue | 49.24M | 49.51M | 50.05M | 48.56M | 45.82M | 41.83M | 37.88M | 34.13M | 30.9M | 28.48M | 25.45M | 23.43M | 22.84M | 21.58M |
Gross Profit | 142.19M | 135.98M | 127.09M | 121.38M | 117.06M | 108.92M | 100.76M | 92.7M | 83.26M | 78.96M | 76.03M | 70.91M | 66.87M | 56.77M |
Operating Income | -60.17M | -57.29M | -59.27M | -57.53M | -53.08M | -52.96M | -52M | -53.44M | -57.5M | -53.26M | -47.47M | -48.4M | -44.44M | -43.88M |
Interest Income | 10.03M | 10.14M | 9.96M | 9.11M | 7.11M | 4.8M | 2.53M | 766K | 191K | 116K | 199K | 336K | 543K | 795K |
Pretax Income | -56.54M | -53.42M | -55.74M | -55.35M | -52.88M | -54.79M | -55.01M | -57.09M | -60.66M | -55.8M | -49.81M | -51.87M | -48.3M | -48.12M |
Net Income | -56.54M | -53.42M | -55.29M | -54.88M | -52.41M | -54.33M | -54.99M | -57.09M | -60.66M | -55.8M | -49.81M | -51.87M | -48.3M | -48.12M |
Selling & General & Admin | 159.71M | 151.72M | 145.03M | 138.44M | 131.25M | 123.12M | 116.32M | 111.39M | 107.62M | 102.47M | 96.39M | 89.66M | 83.82M | 77.03M |
Research & Development | 42.65M | 41.55M | 41.32M | 40.46M | 38.88M | 38.76M | 36.45M | 34.75M | 33.14M | 29.75M | 27.11M | 29.65M | 27.49M | 23.62M |
Other Expenses | 519K | 633K | 441K | -64K | -58K | -218K | -190K | -174K | -181K | -137K | -24K | -18K | -30K | -80K |
Operating Expenses | 202.37M | 193.28M | 186.35M | 178.9M | 170.14M | 161.88M | 152.77M | 146.14M | 140.76M | 132.22M | 123.5M | 119.31M | 111.31M | 100.65M |
Interest Expense | 6.91M | 6.9M | 6.87M | 6.87M | 6.85M | 6.17M | 5.1M | 4M | 2.92M | 2.52M | 2.52M | 2.67M | 3.26M | 3.83M |
Selling & Marketing Expenses | 461K | 461K | 461K | 347K | 347K | 347K | 347K | 221K | 221K | 221K | 221K | 194K | 194K | 194K |
Cost & Expenses | 251.6M | 242.78M | 236.4M | 227.46M | 215.96M | 203.71M | 190.64M | 180.27M | 171.66M | 160.7M | 148.94M | 142.74M | 134.15M | 122.23M |
Income Tax Expense | 43K | 43K | -407K | -466K | -466K | -466K | -173K | -104K | -104K | -104K | 53K | 410K | 410K | 410K |
Shares Outstanding (Basic) | 39.62M | 39.26M | 39.05M | 38.87M | 38.77M | 38.53M | 37.61M | 35.3M | 35.14M | 34.75M | 34.93M | 34.74M | 34.53M | 34.34M |
Shares Outstanding (Diluted) | 39.62M | 39.26M | 39.05M | 38.87M | 38.77M | 38.53M | 37.61M | 35.3M | 35.14M | 35.02M | 34.93M | 34.74M | 34.53M | 34.34M |
EPS (Basic) | -1.44 | -1.37 | -1.43 | -1.43 | -1.39 | -1.48 | -1.54 | -1.63 | -1.74 | -1.61 | -1.44 | -1.51 | -1.42 | -1.43 |
EPS (Diluted) | -1.44 | -1.37 | -1.43 | -1.43 | -1.39 | -1.48 | -1.54 | -1.63 | -1.74 | -1.61 | -1.44 | -1.51 | -1.42 | -1.43 |
EBITDA | -45.89M | -45.33M | -47.62M | -48.97M | -46.63M | -46.96M | -48.57M | -50.37M | -55.34M | -51.14M | -45.51M | -48.02M | -44.02M | -43.34M |
EBIT | -49.63M | -46.52M | -48.87M | -48.48M | -46.03M | -48.62M | -49.91M | -53.09M | -57.74M | -53.28M | -47.29M | -49.2M | -45.05M | -44.29M |
Depreciation & Amortization | 3.73M | 3.74M | 3.79M | 3.8M | 3.69M | 3.49M | 3.17M | 2.8M | 2.48M | 2.18M | 1.92M | 1.73M | 1.58M | 1.46M |